Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for Post-operative Pain in Total Knee Arthroplasty
NCT02466022Phase 3Completed
- Sponsor
- University of Saskatchewan
- Start
- Jun 2015
- Primary completion
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial of dexmedetomidine in postoperative pain, sponsored by University of Saskatchewan. Primary endpoint: Total Morphine Consumption at 24 hours. Started Jun 2015; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02466022.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02466022.